Source disclosure: February 12, 2026
Human Metabolome Technologies,Inc. [6090.T]
TOKYO, Feb 18 (Pulse News Wire) – Human Metabolome Technologies,Inc. (6090.T) reported consolidated results for Q2 FY2026 (ending June 2026).
7% YoY). 2%). net profit attributable to shareholders was ¥43 million (-52.9%).
14 billion with an equity ratio of 84.6%. For the next fiscal year, the company forecasts 60 billion (+10.0%).
Note: Financial figures from the earnings presentation have been removed pending correction. For accurate figures, refer to the company's earnings summary (kessan tanshin) filed separately on TDNet.
AI-translated content. 🟢 Confidence: High See terms •Financial results — FY2026/6 (consolidated)
| Metric | Current | YoY |
|---|---|---|
| Revenue | ¥659M | -3.7% |
| Operating profit | ¥46M | -55.2% |
| Net profit | ¥43M | -52.9% |
Next period forecast
Revenue
¥1,600M
+10.0%Op. profit
¥300M
+20.2%Net profit
¥260M
+1.4%Source: TDNet filing · Figures in millions of yen